Skip to content

Clinical trials

Withdrawn Phase 1/2 Leukemia, Lymphocytic, Chronic, B-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 1/2 Status: Withdrawn Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20082
20091
20111
20141
20162
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
Alliance for Clinical Trials in Oncology1
Fred Hutchinson Cancer Center1
GlaxoSmithKline1
Masonic Cancer Center, University of Minnesota1
Mayo Clinic1
MedImmune LLC1
Scripps Health1
University of Michigan Rogel Cancer Center1
University of Nebraska1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell12
Leukemia6
Precursor Cell Lymphoblastic Leukemia-Lymphoma6
Burkitt Lymphoma5
Leukemia, Myeloid, Acute5
Lymphoma, B-Cell, Marginal Zone5
Lymphoma, Follicular5
Lymphoma, Mantle-Cell5
Lymphoma, Non-Hodgkin5
Myelodysplastic Syndromes4

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.